Cargando…

One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii

The filamentous fungus Ashbya gossypii is currently used for the industrial production of vitamin B2. Furthermore, the ability of A. gossypii to grow using low‐cost substrates together with the inexpensive downstream processing makes this fungus an attractive biotechnological chassis. Indeed, the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez, Alberto, Muñoz‐Fernández, Gloria, Ledesma‐Amaro, Rodrigo, Buey, Rubén M., Revuelta, José L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801137/
https://www.ncbi.nlm.nih.gov/pubmed/31055883
http://dx.doi.org/10.1111/1751-7915.13425
_version_ 1783460518243074048
author Jiménez, Alberto
Muñoz‐Fernández, Gloria
Ledesma‐Amaro, Rodrigo
Buey, Rubén M.
Revuelta, José L.
author_facet Jiménez, Alberto
Muñoz‐Fernández, Gloria
Ledesma‐Amaro, Rodrigo
Buey, Rubén M.
Revuelta, José L.
author_sort Jiménez, Alberto
collection PubMed
description The filamentous fungus Ashbya gossypii is currently used for the industrial production of vitamin B2. Furthermore, the ability of A. gossypii to grow using low‐cost substrates together with the inexpensive downstream processing makes this fungus an attractive biotechnological chassis. Indeed, the production in A. gossypii of other high‐added value compounds such as folic acid, nucleosides and biolipids has been described. Hence, the development of new methods to expand the molecular toolkit for A. gossypii genomic manipulation constitutes an important issue for the biotechnology of this fungus. In this work, we present a one‐vector CRISPR/Cas9 system for genomic engineering of A. gossypii. We demonstrate the efficiency of the system as a marker‐less approach for nucleotide deletions and substitutions both with visible and invisible phenotypes. Particularly, the system has been validated for three types of genomic editions: gene inactivation, the genomic erasure of loxP scars and the introduction of point mutations. We anticipate that the use of the CRISPR/Cas9 system for A. gossypii will largely contribute to facilitate the genomic manipulations of this industrial fungus in a marker‐less manner.
format Online
Article
Text
id pubmed-6801137
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68011372019-10-22 One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii Jiménez, Alberto Muñoz‐Fernández, Gloria Ledesma‐Amaro, Rodrigo Buey, Rubén M. Revuelta, José L. Microb Biotechnol Brief Reports The filamentous fungus Ashbya gossypii is currently used for the industrial production of vitamin B2. Furthermore, the ability of A. gossypii to grow using low‐cost substrates together with the inexpensive downstream processing makes this fungus an attractive biotechnological chassis. Indeed, the production in A. gossypii of other high‐added value compounds such as folic acid, nucleosides and biolipids has been described. Hence, the development of new methods to expand the molecular toolkit for A. gossypii genomic manipulation constitutes an important issue for the biotechnology of this fungus. In this work, we present a one‐vector CRISPR/Cas9 system for genomic engineering of A. gossypii. We demonstrate the efficiency of the system as a marker‐less approach for nucleotide deletions and substitutions both with visible and invisible phenotypes. Particularly, the system has been validated for three types of genomic editions: gene inactivation, the genomic erasure of loxP scars and the introduction of point mutations. We anticipate that the use of the CRISPR/Cas9 system for A. gossypii will largely contribute to facilitate the genomic manipulations of this industrial fungus in a marker‐less manner. John Wiley and Sons Inc. 2019-05-05 /pmc/articles/PMC6801137/ /pubmed/31055883 http://dx.doi.org/10.1111/1751-7915.13425 Text en © 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Brief Reports
Jiménez, Alberto
Muñoz‐Fernández, Gloria
Ledesma‐Amaro, Rodrigo
Buey, Rubén M.
Revuelta, José L.
One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
title One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
title_full One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
title_fullStr One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
title_full_unstemmed One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
title_short One‐vector CRISPR/Cas9 genome engineering of the industrial fungus Ashbya gossypii
title_sort one‐vector crispr/cas9 genome engineering of the industrial fungus ashbya gossypii
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801137/
https://www.ncbi.nlm.nih.gov/pubmed/31055883
http://dx.doi.org/10.1111/1751-7915.13425
work_keys_str_mv AT jimenezalberto onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii
AT munozfernandezgloria onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii
AT ledesmaamarorodrigo onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii
AT bueyrubenm onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii
AT revueltajosel onevectorcrisprcas9genomeengineeringoftheindustrialfungusashbyagossypii